COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,784 Articles (22,523 medRxiv, 8,261 bioRxiv)

Most recent first Previous |  Page 2503: Articles 25021-25030  | Next

Contact Tracing Evaluation for COVID-19 Transmission during the Reopening Phase in a Rural College Town
Moon, S. a., Scoglio, C.
10.1101/2020.06.24.20139204 — Posted: 2020-06-26
Excess of Cardiovascular Deaths During the COVID-19 Pandemic in Brazilian Capital Cities
Brant, L. C. C., Nascimento, B. R., Teixeira, R., Lopes, M. A. Q., Malta, D. C., Oliveira, G. M. M., Ribeiro, A. L. P.
10.1101/2020.06.24.20139295 — Posted: 2020-06-26
Persistence of viral RNA, widespread thrombosis and abnormal cellular syncytia are hallmarks of COVID-19 lung pathology
Giacca, M., Bussani, R., Schneider, E., Zentilin, L., Collesi, C., Ali, H., Braga, L., Secco, I., Volpe, M. C., Colliva, A., Zanconati, F., Berlot, G., Silvestri, F., Zacchigna, S.
10.1101/2020.06.22.20136358 — Posted: 2020-06-26
Treatment of ARDS and hyperinflammation in COVID-19 with IL-6 antagonist Tocilizumab: a tertiary care experience from Pakistan
Nasir, N., Mahmood, S. F., Habib, K., Khanum, I., Jamil, B.
10.1101/2020.06.23.20134072 — Posted: 2020-06-26
Tocilizumab and steroid treatment in patients with severe Covid-19 pneumonia.
Mikulska, M., Nicolini, L. A., Signori, A., Di Biagio, A., Sepulcri, C., Russo, C., Dettori, S., Berruti, M., Sormani, M. P., Giacobbe, D. R., Vena, A., De Maria, A., Dentone, C., Taramasso, L., Mirabella, M., Magnasco, L., Mora, S., Delfino, E., Toscanini, F., Balletto, E., Alessandrini, A. I., Baldi, F., Briano, F., Camera, M., Dodi, F., Ferrazin, A., Labate, L., Mazzarello, G., Pincino, R., Portunato, F., Tutino, S., Barisione, E., Bruzzone, B., Orsi, A., Schenone, E., Rosseti, N., Sasso, E., Da Rin, G., Pelosi, P., Beltramini, S., Giacomini, M., Icardi, G., Gratarola, A., Bassetti, M.
10.1101/2020.06.22.20133413 — Posted: 2020-06-26 Discussion: Onsite
Seroprevalence of SARS-CoV-2 IgG Specific Antibodies among Healthcare Workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave
Fernandez-Rivas, G., Quirant-Sanchez, B., Gonzalez, V., Dolade, M., Martinez-Caceres, E., Pina, M., Matllo, J., Estrada, O., Blanco, I.
10.1101/2020.06.24.20135673 — Posted: 2020-06-26
COVID-19 Antibody in Thai Community Hospitals
Nopsopon, T., Pongpirul, K., Hiransuthikul, N.
10.1101/2020.06.24.20139188 — Posted: 2020-06-26
Epidemiological model with anomalous kinetics - The Covid-19 pandemics
TIRNAKLI, U., Tsallis, C.
10.1101/2020.06.24.20139287 — Posted: 2020-06-26
Novel coronavirus (COVID-19) Outbreak in Iraq: The First Wave and Future Scenario
Sarhan, A. R., Flaih, M. H., Hussein, T. A., Hussein, K. R.
10.1101/2020.06.23.20138370 — Posted: 2020-06-26
Exploring Causal relationship between risk factors and vulnerability to COVID-19Cases of Italy, Spain, France, Greece, Portugal, Morocco and South Africa
YOUMNI, A., CHAYKH, M.
10.1101/2020.06.24.20139121 — Posted: 2020-06-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).